Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPA-EAT: Dapagliflozin Effect on Epicardial Adipose Tissue in Asymptomatic Heart Failure
jRCT1051220025Completed
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dapagliflozin in heart failure (HF) (2 arms). Primary endpoint: Change from baseline in EAT volume. Started Aug 2022; status: completed.
02
Drugs
dapagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on jRCT1051220025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051220025.